CEO
Birth year: 1972
Education: M. Sc. Pharmacy, PhD Pharmaceutical Technology from University of Copenhagen, School of Pharmaceutical Sciences
Share holdings: 15
Anita joined Probi in April 2022 as the Vice President of R&D, and since April 2023 has been the CEO of Probi.
Anita is also serving as director of the board of Blis Technologies Ltd, where Probi is a substantial product holder, and she is an elected board member of International Association of Probiotics (IPA) and on the board of IPA Europe.
Throughout her career Anita has been working with product development and held leadership positions in global consumer healthcare companies, such as Ferrosan, Pfizer Consumer Healthcare, Novozymes, and USP Zdrowie.
Anita is passionate about promoting the advantages of good bacteria by delivering customer relevant innovations supported by science.
CEO
CFO
Birth year: 1966
Education: M.Sc. Economics & Business Administration, Copenhagen Business School
Share holdings: 191
Per joined Probi in November 2023 from ABF Ingredients (A division of Associated British Food) where he served as CFO. Previous to ABF Ingredients, Per had senior leadership roles in Finance, IT and Supply Chain in Chr. Hansen and CP Kelco. Throughout his career, he has demonstrated value driven leadership skills and a deep understanding of financial management, business development & M&A.
CFO
VP HR & Sustainability
Birth year: 1983
Education: Bachelor's degree in Psychology and minor in Management, Hood College Maryland
Share holdings: 0
Basudha Bhattarai-Johansson joined Probi as Vice President HR in January 2020. Prior to Probi, Basudha worked for Bristol-Myers Squibb as Head of HR for Nordics. Before Bristol-Myers Squibb, Basudha has held Northern European HR roles in IQVIA (previously IMS Health). Basudha brings with her in depth experience in strategic HRM, M&As and change management.
VP HR & Sustainability
Vice President Research & Development
Birth year: 1973
Education: M.Sc. Pharmacy, Ph.D. Molecular Microbiology, University of Copenhagen.
Christina joined Probi in January 2023 as Director of Discovery & Clinical Research and assumed the role as Sr. Director R&D in September the same year. Member of the management team from 2024. Christina has broad microbiology and leadership experience from academic research as Associate Professor at Copenhagen University and leading industrial development of microbial solutions in the form of Probiotics, dairy cultures and Live Biotherapeutics Products at Bacthera and Chr Hansen.
Vice President Research & Development
Vice President of Operations (Interim)
Birth year: 1970
Education: M. Eng. Industrial Engineering, B. Sc Mechanical Engineering from Pennsylvania State University
Share holdings: 0
Jim joined Probi in February 2024 as the Vice President of Operations (Interim).
Throughout his career Jim has been working in manufacturing and supply chain and held leadership positions in global healthcare companies such as Haleon, GlaxoSmithKline (GSK), Pfizer and Wyeth Pharmaceuticals.
Additionally, Jim has experience in telecommunications at Lucent Technologies and automotive at Ford Electronics.
Jim is passionate about operations and as a confident change agent is looking to develop more well-defined processes that deliver business results.
Vice President of Operations (Interim)
Vice President, Commercial
Birth year: 1967
Education: Bachelor’s and Master’s degrees in Political science
Ethan has more than 20 years of experience within a senior commercial capacity, culminating in his most recent position as Senior VP Early Life Nutrition within Pantheryx. Prior to this, Ethan worked within DSM for 10 years across various senior commercial positions in their nutritional business.Ethan is an entrepreneurial and principled leader who consistently delivers financial and strategic objectives through development of high-performing cross-functional teams.
Vice President, Commercial
Chairman of the board
Birth year: 1964
Education: Bachelor of Economics, HEC Paris, and Veterinary Science, VetAgro Sup.
Share holdings: 0
Chairman of the Board since 2015. President of Symrise. Previous leadership roles at Air Liquide, Danisco, Rhodia, Rhône-Poulenc, Mérial and Pfizer.
Chairman of the board
Board member
Birth year: 1962
Education: M.Sc. in Biochemistry, Copenhagen University and Marketing Economist diploma from IHM.
Share holdings: 500
Board member since 2017. Owner of Scandinavian Insight Consulting AB. Former CEO of MorgonTidig Distribution KB and Jetpak. Has previously served in leadership roles at Danzas ASG Eurocargo AB, Carl Zeiss AB and Beckman Coulter AB.
Board member
Board member
Birth year: 1980
Education: PhD in economics, Karlsruhe Institute of Technology (KIT), Karlsruhe.
Share holdings: 0
Board member since 2019. President Scent & Care and Executive Board member Symrise AG. Jörn has experience from both a previous assignment as board member (2014-2016) at Probi and his position as CFO of the company (2017-2018). He has also worked for The Boston Consulting Group, Hamburg and Bayer AG, Leverkusen, Germany.
Board member
Board member
Birth year: 1971
Education: Bachelor of Human Resources from Lund University, Business Administration & Sociology from
UC Berkeley (University of California), Master of European Studies from Brygge.
Share holdings: 0
Board member since 2020. Head of talent management and company development at Grenspecialisten AB. More than 20 years of international experience in HR, business management, corporate governance, growth, strategy, CSR, establishment in new markets and communication
Board member
Board member
Birth year: 1959
Education: Doctor of Biochemistry & Pharmacology, J.W. von Goethe University, Frankfurt a.Main, Germany, Postgraduate specialization in Immunology at the Ludwig Institute of Cancer Research & Lausanne University Hospital (CHUV)
Share holdings: 0
Board member since 2024. Senior Executive in research & development, different leadership roles across Nestlé R&D and the Onco-Immunology Division, Lausanne University Hospital (CHUV),
Board member
